Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS ‐ CoV ‐2 infections, 2022–23: a retrospective analysis of ANZICS data
Medical Journal of Australia · 2024
DOI: 10.5694/mja2.52390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, 2024. Verfasst von Alastair Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Australia and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC. Hauptthemen laut MEDLINE: COVID-19, Intensive Care Units, Hospital Mortality, Length of Stay. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Objectives
To compare in‐hospital mortality and intensive care unit (ICU) length of stay for people admitted to Australian and New Zealand ICUs during 2022–23 with coronavirus disease 2019 (COVID‐19) pneumonitis, incidental or exacerbating severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections, or without SAR‐CoV‐2 infections. Study design Retrospective cohort study; analysis of Australian and New Zealand Intensive Care Society (ANZICS) Adult Patient Database data. Setting, participants Adults (16 years or older) admitted to participating ICUs in Australia or New Zealand, 1 January 2022 – 30 June 2023. Major outcome measures The primary outcome was in‐hospital mortality, the secondary outcome ICU length of stay, each by SARS‐CoV‐2 infection attribution classification: primary COVID‐19; exacerbating SARS‐CoV‐2 infection (SARS‐CoV‐2 infection was a contributing factor to the primary cause of ICU admission); incidental SARS‐CoV‐2 infections (SARS‐CoV‐2 infection detected during ICU admission but did not contribute to admission diagnosis); no SARS‐CoV‐2 infection.
Results
A total of 207 684 adults were admitted to 195 Australian and New Zealand ICUs during 2022–23; 2674 people (1.3%) had incidental SARS‐CoV‐2 infections, 4923 (2.4%) exacerbating infections, and 3620 (1.7%) primary COVID‐19. Unadjusted in‐hospital mortality for people with incidental SARS‐CoV‐2 infections (288 deaths, 10.8%) was lower than for those with exacerbating infections (928 deaths, 18.8%) or primary COVID‐19 (830 deaths, 22.9%), but higher than for patients without SARS‐CoV‐2 infections (15 486 deaths, 7.9%). After adjusting for illness severity, frailty, geographic region, and type of hospital, mortality was higher for patients with incidental SARS‐CoV‐2 infections (adjusted odds ratio [aOR], 1.28; 95% confidence interval [CI], 1.10–1.50), exacerbating infections (aOR, 1.35; 95% CI, 1.22–1.48), or primary COVID‐19 (aOR, 2.54; 95% CI, 2.30–2.81) than for patients without SARS‐CoV‐2 infections. After adjusting for diagnosis and illness severity, ICU stays were longer for people with incidental (mean difference, 3.3 hours; 95% CI, 2.4–4.2 hours) or exacerbating infections (0.8 hours; 95% CI, 0.2–1.5 hours) than for those without SARS‐CoV‐2 infections.
Conclusion
Risk‐adjusted in‐hospital mortality and ICU length of stay are higher for people admitted to intensive care who have concomitant SARS‐CoV‐2 infections than for people who do not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Australia and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC.
- St Vincent's Hospital, Melbourne, VIC.
- The Alfred, Melbourne, VIC.
- Australian Department of Health and Aged Care, Canberra, ACT.
- Centre for Outcome and Resource Evaluation, Australian and New Zealand Intensive Care Society, Melbourne, VIC.
ORCID-Profile: Alastair Brown, David Pilcher
Zitieren
APA
Brown, A., Udy, A., Kirk, M., Bennett, S., Chavan, S., Huckson, S., & Pilcher, D. (2024). Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS ‐ CoV ‐2 infections, 2022–23: a retrospective analysis of ANZICS data. Medical Journal of Australia. https://doi.org/10.5694/mja2.52390
Vancouver
Brown A, Udy A, Kirk M, Bennett S, Chavan S, Huckson S, et al. Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS ‐ CoV ‐2 infections, 2022–23: a retrospective analysis of ANZICS data. Medical Journal of Australia. 2024. doi:10.5694/mja2.52390
BibTeX
@article{Brown2024,
author = {Brown, Alastair and Udy, Andrew and Kirk, Martyn and Bennett, Sonya and Chavan, Shaila and Huckson, Sue and Pilcher, David},
title = {Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS ‐ CoV ‐2 infections, 2022–23: a retrospective analysis of ANZICS data},
journal = {Medical Journal of Australia},
year = {2024},
doi = {10.5694/mja2.52390}
}
EUVIMED